Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$333,813
-$1,626 QoQ
Shares Held
2,130
-3.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,071
of 1,603 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Braun-Bostich & Associates Inc. holds $3,399,809 across 6 Drug Manufacturers - General names. NVS ranks #5 (9.8% of the industry book) .
All Filings in NVS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $333,813 | 2,130 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $335,439 | 2,196 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $307,863 | 2,233 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $272,766 | 2,127 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $276,386 | 2,284 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $254,174 | 2,280 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $216,125 | 2,221 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $270,757 | 2,354 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $234,850 | 2,206 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $30,783 | 354 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $72,404 | 829 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $68,351 | 829 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||